Ultragenyx Pharmaceutical Inc.
Asset & Liabilities Breakdown
Asset Breakdown FY2019
Total Assets: $1.14B
Liabilities Breakdown FY2019
Total Liabilities: $481.7M
Asset Breakdown
Total Assets: $1.14B
| Line Item | Value | % of Total |
|---|---|---|
| Cash & Equivalents | $433.6M | 38.2% |
| Accounts Receivable | $32.8M | 2.9% |
| Inventory | $11.5M | 1.0% |
| Property, Plant & Equipment | $44.3M | 3.9% |
| Goodwill | $44.4M | 3.9% |
| Intangible Assets | $129.0M | 11.4% |
| Other Assets | $439.8M | 38.7% |
Liabilities Breakdown
Total Liabilities: $481.7M
| Line Item | Value | % of Total |
|---|---|---|
| Accounts Payable | $12.9M | 2.7% |
| Long-Term Debt | $0 | 0.0% |
| Other Liabilities | $468.9M | 97.3% |